Evaric Pharma Private Limited

Evaric Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24100TG2015PTC102128 Incorporated 08 December 2015 ROC Hyderabad HQ Hyderabad, Telangana, India
Struck Off Private Limited Company pharma
Data last updated
Revenue · FY 2019
-
Latest filing
EBITDA · FY 2019
*****
▼ 81.08% YoY
Net profit · FY 2019
*****
▼ 373.47% YoY
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
11 yrs
Est. 2015
Last financials
Mar 2022
Balance sheet date

About Evaric Pharma Private Limited

Data last updated: 22 July 2025

Evaric Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Hetero Labs Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 December 2015.

Registered with ROC Hyderabad under CIN U24100TG2015PTC102128.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Bhaskarreddy Pabbatireddy and Sudhakar Reddy Avuthu.

Last AGM: 22 September 2022. Financial statements filed for year ended 31 March 2022. Office: H.No. 8 – 3 – 166/7/1 Erragadda, Hyderabad, Telangana, India – 500018.

It operated as a subsidiary of Hetero Labs Limited.

The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk.

Company Details of Evaric Pharma Private Limited
CIN U24100TG2015PTC102128
Registration Number 102128
Incorporation Date 08 December 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 22 September 2022
Date of Balance Sheet 31 March 2022
Parent Company Hetero Labs Limited
Compliance Status Active Compliant
Key People
Bhaskarreddy Pabbatireddy Director Sudhakar Reddy Avuthu Director Chittajallu Gopalakrishna Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    H.No. 8 – 3 – 166/7/1 Erragadda, Hyderabad, Telangana, India – 500018
  • Industry
    Pharma, Drug Formulation & Development
Company report
Evaric Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Evaric Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Evaric Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Evaric Pharma Private Limited

Evaric Pharma Private Limited is audited by M V NARAYANA REDDY & CO for the financial year 2019. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
M V NARAYANA REDDY & CO blur-value blur-value blur-value

Board of Directors of Evaric Pharma Private Limited

Evaric Pharma Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Bhaskarreddy Pabbatireddy
Also directs: Aspiro Pharma Limited, Annora Pharma Private Limited, Hetero Biopharma Limited and 1 more
Director 08 Dec 2015 10 Years 7 Months As last reported
Sudhakar Reddy Avuthu
Also directs: Yatnam Lab Limited, Kemgia Traders Private Limited
Director 08 Sep 2017 8 Years 10 Months As last reported
Chittajallu Gopalakrishna
Also directs: Wallet Pharma Private Limited, Anaika Industries Limited, Actero Pharma Private Limited and 2 more
Director 20 Jun 2017 9 Years 0 Months As last reported
View all directors

Financials of Evaric Pharma Private Limited FY 2022 filings available

Evaric Pharma Private Limited reported revenue of ₹- (up ) for FY 2019. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
Profit
***** ▼ -373.47%
EBITDA
***** ▼ -81.08%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Evaric Pharma Private Limited

As of FY 2019, Evaric Pharma Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Evaric Pharma Private Limited

Evaric Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Evaric Pharma Private Limited

View historical data on people associated with Evaric Pharma Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Evaric Pharma Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Evaric Pharma Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Evaric Pharma Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Evaric Pharma Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Evaric Pharma Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Evaric Pharma Private Limited

MSME Payment Delays by Evaric Pharma Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Evaric Pharma Private Limited

Subsidiaries & Group Companies of Evaric Pharma Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Evaric Pharma Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Evaric Pharma Private Limited

MCA Filings & Documents of Evaric Pharma Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Evaric Pharma Private Limited

Activity
22 Sep 2022
Evaric Pharma Private Limited last Annual general meeting of members was held on 22 Sep 2022 as per latest MCA records.
Activity
31 Mar 2022
Evaric Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
Directors
08 Sep 2017
Sudhakar Reddy Avuthu was appointed as a Director on 08 Sep 2017 & has been associated with this company since 8 years 10 months.
Directors
20 Jun 2017
Chittajallu Gopalakrishna was appointed as a Director on 20 Jun 2017 & has been associated with this company since 9 years 21 days.
Directors
08 Dec 2015
Bhaskarreddy Pabbatireddy was appointed as a Director on 08 Dec 2015 & has been associated with this company since 10 years 7 months.
Activity
08 Dec 2015
Evaric Pharma Private Limited was registered on 08 Dec 2015 with Roc Hyderabad & aged 10 years 7 months as per MCA records.

Frequently Asked Questions about Evaric Pharma Private Limited

Evaric Pharma Private Limited has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Evaric Pharma Private Limited is a struck-off private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 08 December 2015 and is registered under CIN U24100TG2015PTC102128. The company has been struck off by the Registrar of Companies and is no longer operational.

The current directors of Evaric Pharma Private Limited are:

The CIN (Corporate Identification Number) of Evaric Pharma Private Limited is U24100TG2015PTC102128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Evaric Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company was active in this sector before being struck off.

The company has its registered office at H.No. 8 – 3 – 16671 Erragadda, Hyderabad, Telangana, India – 500018.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available